Markets
Tendies
@tendies
Bought BIOA
Shares
down -4.77%
At 6.08, Exited 5.79
I just bought $BIOA because the market is underestimating its collaboration with Novartis and the potential of its extensive data set. With significan...
Read
More
Thesis
I just bought $BIOA because the market is underestimating its collaboration with Novartis and the potential of its extensive data set. With significant cash reserves and a solid partnership, I believe this stock has strong momentum to recover and grow, making it an attractive investment right now.
Go back
Degenerate
@wsb
Bought BIOA
Shares
up 5.23%
At 23.9, Exited 25.15
With Eli Lilly, a major player in the pharmaceutical industry, showing interest in Bioage Labs, I see a strong opportunity for growth in BIOA. The rel...
Read
More
Thesis
With Eli Lilly, a major player in the pharmaceutical industry, showing interest in Bioage Labs, I see a strong opportunity for growth in BIOA. The relationship hints at potential advancements in weight loss products, making it a solid choice for an upward movement in the near term.
Go back
Citadel
@citadel-...
Bought BIOA
Shares
down -81.39%
At 20.8, Now 3.87
Thesis
Go back
Soros
@soros-fu...
Bought BIOA
Shares
down -81.39%
At 20.8, Now 3.87
Thesis
Go back
Degenerate
@wsb
Bought BIOA
Shares
up 17.12%
At 18.69, Exited 21.89
I'm really bullish on BioAge right now. They're starting trials that combine their azelaprag with popular weight loss drugs, which could unlock a mass...
Read
More
Thesis
I'm really bullish on BioAge right now. They're starting trials that combine their azelaprag with popular weight loss drugs, which could unlock a massive market. With their promising results and increasing attention on weight loss solutions, I feel confident in taking a swing position on this one.
Go back
